Navigation Links
Promising biomarker and candidate tumor suppressor gene identified for colorectal cancer
Date:6/17/2009

today.

"Genetic diagnosis of colorectal cancers and meaningful adenomas has now reached a new phase that, when further fine-tuned, may carry the promise of becoming a suitable and affordable means of prevention and early detection of colorectal cancer in the general population," he writes.


'/>"/>

Contact: Steve Graff
jncimedia@oxfordjournals.org
301-841-1285
Journal of the National Cancer Institute
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Promising drug combination may help those with ocular melanoma that has spread
2. Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis
3. Molecule Promising Against Huntingtons Disease
4. Computerized training of working memory is a promising therapeutic strategy in ADHD
5. Baicalin might be a promising therapeutic tool for severe acute pancreatitis
6. Initial Evaluation of New Nucleus Removal Device Provides Promising Results
7. Promising new TB drug given special status by US and European regulators
8. New Drug Promising Against Tough-to-Treat Kidney Cancer
9. Einstein scientists treat cancer as an infectious disease -- with promising results
10. Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
11. Protalix BioTherapeutics prGCD Named One of the Five Most Promising Drugs Entering Phase III Trials by Thomson Scientific

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , WASHINGTON, Nov. 20 /PRNewswire-U...olic Bishops urged the Senate to make essential ch...lace federal law on abortion funding and conscienc... care for immigrants and include strong provisions...led the Senate health care bill an "enormous disap...
(Date:11/20/2009)..., , CHICAGO, Nov. 20 /PRNewswire-USNewswir...asked the U.S. Food and Drug Administration (FDA) ...-whitening chemicals. ,, Citing concern about ...ministered without the benefit of professional con...tion said that the application of chemically based...
(Date:11/20/2009)..., , LAS VEGAS, Nov. 20 /PRNewswire-USNewswi...ry, Executive Director of the Nevada Health Care A...ion (NHCA) commends and thanks Senate Majority Lea...tion a step closer toward our goal of protecting e...sing home care, and preserving the strength and vi...
(Date:11/20/2009)..., Spot blood pressure readings in children with c...nsion even during doctor,s office visits increas...ording to research from Johns Hopkins Children,s C...ings appears online in the Journal of American Soc...od pressure measurements obtained during regular d...
(Date:11/20/2009)... Consumers save up to one-third buying 90-day supp...lthDay News) -- Buying a three-month supply of pre...ying a one-month supply, according to a new study....ns filled for 395 drugs between 2000 and 2005, and...ly instead of a one-month supply saved an average ...
Breaking Medicine News(10 mins):Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:High blood pressure easy to miss in children with kidney disease 2Health News:Three-Month Supply Lowers Drug Costs 2
... in B2B,solutions for transaction interoperability...fecs Healthcare Accelerator Suite to automate data...eal-time and batch modes,within the product and de...,challenges, state Medicaid programs are increasin...
...pt. 15 iMedica Corporation ("iMedica"),announced ...Misys,Healthcare Systems LLC ("Misys")., Under th...r the iMedica,PRM 2008 practice management (PM) an...e a license to Misys for the,new version of the iM...
...llion grant from the National Cancer Institute to ...gram that provides personally tailored education i...er of Hispanic patients who receive colorectal can... in primary care physician,s offices in New York C...
...ssor of biological sciences at Virginia Tech, has ...innate immunity network and human chronic inflamma...iabetes, and neurodegenerative diseases. The findi...rchers and physicians have long recognized that th...
...sage boards, videos and advice , , MONDAY,...lp cancer patients learn more about how they can p...unched by Northwestern University in Chicago. , "...to terms with their recent cancer diagnosis and im...
...ion (Nasdaq: OCCF ), announced that it will relea...oday, September 15, 2008. The third,quarter result...ded July,31, 2008. In conjunction with its release...rence call should call,(888) 868-9083. For interes...
Other Medicine News:Health News:Unisys Selects Edifecs Healthcare Accelerator Suite(TM) for MMIS System 2Health News:iMedica Announces Agreement with Misys 2Health News:UC Davis doctors use multimedia to increase colorectal cancer screening among Hispanics 2Health News:Key protein molecule linked to diverse human chronic inflammatory diseases 2Health News:Web Site Helps Cancer Patients With Fertility Preservation 2Health News:Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 2008 Results 2Health News:Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 2008 Results 3
(Date:11/20/2009)...20 Boston Scientific Cor...s received 510(k) clearance from the U.S. Food and... market its WallFlex® Fully Covered Esophagea...strictures (obstructions) caused by tumors in pati...cancer. ,, (Photo: http://www.newscom.com/cg...
(Date:11/20/2009)...irstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) tod...xecutive Officer, and Greg Browne, Chief Financial...ffray Health Care Conference in New York on Wednes...ence session and webcast will be audio only and no...ill host a webcast of the presentation live and by...
(Date:11/20/2009)...Newswire-FirstCall/ -- BD (Becton, Dickinson and C...ion of its acquisition of HandyLab, Inc., an Ann A...ufactures molecular diagnostic assays and automati...nnounced an exclusive agreement for BD to develop ... Jaguar(TM) platform, the first fully integrated m...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Miriam Hospital researcher receives more than 2412 million to study weight control 10359 1Miriam Hospital researcher receives more than 2412 million to study weight control 10359 2Miriam Hospital researcher receives more than 2412 million to study weight control 10359 3MSU becoming center of excellence for Parkinsons research 10356 1MSU becoming center of excellence for Parkinsons research 10356 2As More Cyclists Hit the Road Serious Injuries Rise 59456 1As More Cyclists Hit the Road Serious Injuries Rise 59456 2
...ival Improvement with Lower Doses of,Dexamethasone...r,Drugs in Newly Diagnosed Myeloma -, NORTH HOLLYW...ternational Myeloma Foundation (IMF) - supporting ...port for myeloma patients,families, researchers a...der lowering the dose of the steroid dexamethasone...
..., 2007 /PRNewswire/ -- Nereus,Pharmaceuticals, Inc...m marine microbial sources, and its collaborators ...s involving its cancer drug,candidates at the Amer...g in Los Angeles April 14-18. Four posters and two...and anti-tumor,activity in several tumor models fo...
Other Medicine Technology:The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 2The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 3Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 2Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 3Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 4Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 5
...ble pre-fabricated orthosis is designed for the ma...hyseal fractures. The lightweight anatomical desig...ue compression for optimal control of humeral segm...der and elbow joints. In addition this brace featu...
Humeral Stabilizing System (HSS)
Functional Arm Brace
.... Control the ankle. This simple concept is the co...hnology. When you lock the heel with our patent-pe... stability and comfort your patient will experienc...wraps around the heel and supports the posterior a...
Medicine Products: